SCHEMBL9082467

SCHEMBL9082467

CC(=O)NCc1ccc(C(=O)CCl)o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.59
ALDH1A1 P00352 5/20 0.59
MAPT P10636 4/20 0.59
RAB9A P51151 2/20 0.59
HTT P42858 2/20 0.51
NPC1 O15118 1/20 0.51
HSD17B10 Q99714 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
RECQL P46063 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 3/20 0.44
ESR1 P03372 1/20 0.43
APOBEC3A P31941 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
MEN1 O00255 1/20 0.42
HDAC1 Q13547 2/20 0.41
HDAC6 Q9UBN7 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9292485 0.84 TSHR (0.49) POLBALDH1A1MAPTRAB9AHTT
SCHEMBL9292668 0.84 ALDH1A1 (0.42) POLBALDH1A1MAPTRAB9AHTT
SCHEMBL9600220 0.80 KMT2A (0.42) POLBALDH1A1MAPTRAB9AHTT
SCHEMBL19458000 0.74 GSK3B (0.46) POLBALDH1A1MAPTRAB9ATDP1
SCHEMBL10061717 0.74 MAPT (0.50) POLBALDH1A1MAPTTDP1KMT2A
SCHEMBL9292488 0.73 POLB (0.39) POLBALDH1A1MAPTRAB9AHTT
SCHEMBL27489609 0.73 NPSR1 (0.42) POLBALDH1A1MAPTRAB9AHTT
SCHEMBL9085793 0.72 ALDH1A1 (0.49) POLBALDH1A1MAPTRAB9AHTT
SCHEMBL9292903 0.72 HTT (0.41) POLBALDH1A1MAPTRAB9AHTT
SCHEMBL9293334 0.71 KMT2A (0.42) POLBALDH1A1HTTTDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5512588-A ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-30 US disclosed
WO-1995018126-A1 FURYLTHIAZOLE AND THEIR USE AS H2-RECEPTOR ANTAGONISM AND ANTIMICROBIAL FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-07-06 WO disclosed
CN-1097010-A Novel furyl thiazole derivatives and salts thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-01-04 CN disclosed
EP-0355612-B1 Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-07-27 EP disclosed
EP-0598906-A1 FURYLTHIAZOLE AND THEIR USE AS H 2?-RECEPTOR ANTAGONISM AND ANTIMICROBIAL FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-06-01 EP disclosed
US-5308857-A Antiulcer agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-03 US disclosed
WO-1994003450-A1 FURYLTHIAZOLE AND THEIR USE AS H2-RECEPTOR ANTAGONISTS AND ANTIMICROBIAL AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-02-17 WO disclosed
WO-1993003028-A1 FURYLTHIAZOLE AND THEIR USE AS H2-RECEPTOR ANTAGONISM AND ANTIMICROBIAL FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-02-18 WO disclosed
EP-0355612-A2 Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-28 EP disclosed